Structure Therapeutics (GPCR) Change in Accured Expenses (2022 - 2026)

Structure Therapeutics' Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$134000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 86.51% year-over-year to -$134000.0; the TTM figure through Mar 2026 stood at $22.4 million (up 129.28% YoY), while the FY2025 annual figure was $21.5 million, up 178.79% from the prior year.
• Change in Accured Expenses was -$134000.0 for Q1 2026 at Structure Therapeutics, down from $15.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $15.0 million in Q4 2025 to a low of -$3.0 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged $2.5 million across 5 years, with a median of $2.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 5526.79% in 2023, then sank 446.67% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $56000.0 in 2022, then soared by 5526.79% to $3.2 million in 2023, then slipped by 4.03% to $3.0 million in 2024, then soared by 396.76% to $15.0 million in 2025, then plunged by 100.89% to -$134000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$134000.0 (Q1 2026), $15.0 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.